Vol 4, Nº 02 (2020)

Description du numéro

The world is in the midst of a COVID-19 pandemic. Till now there is no effective treatment of this disease; what we have that is a magic tool- vaccine. As of February 2021, ten vaccines are authorized by at least one national regulatory authority for public use: two RNA vaccines (the Pfizer–BioNTech vaccine and the Moderna vaccine), four conventional inactivated vaccines (BBIBP-CorV from Sinopharm, BBV152 from Bharat Biotech, CoronaVac from Sinovac, and WIBP from Sinopharm), three viral vector vaccines (Sputnik V from the Gamaleya Research Institute, the Oxford–AstraZeneca vaccine, and Ad5-nCoV from CanSino Biologics), and one peptide vaccine (EpiVacCorona from the Vector Institute).

Sommaire

Editorial

Original Article

Voir tous les numéros